The decisive fact about Meta’s smart glasses is where they sell. EssilorLuxottica moved more than seven million AI glasses in 2025, more than triple the two million it had sold across the two prior years, and the mass channel that absorbed them was the eyewear counter rather than the electronics aisle. Face-worn artificial intelligence has found its first retail home, and it is the optical store that also dispenses reading glasses and bills a vision plan. The hardware is new; the point of sale is a century old. That relocation is the story, larger than the camera or the assistant fixed to the frame.

Most coverage read this as a product hit or a stock story and walked past the channel beneath it. Reporters tallied the units and Meta’s $3.5 billion purchase of just under 3% of the Ray-Ban maker, then treated the optical store as the box the device shipped in. EssilorLuxottica runs roughly 18,000 retail locations across dozens of banners, among them LensCrafters, Sunglass Hut, Target Optical and Pearle Vision. It also owns EyeMed, the vision-insurance arm that pays for what those counters dispense. A stake just under 3% buys influence, not control: EssilorLuxottica held that store network and those reimbursement rails before Meta invested, and holds them on the same terms now. What changed is that Meta has a seat at the table where the gadget becomes a claim against a customer’s benefits.

The store is the strategy.

The eyewear counter does three things a consumer-electronics store cannot. It measures a prescription, fits the frame to a face, and bills the cost to vision insurance. The fit is not cosmetic: a mismeasured pupillary distance or a wrong tilt yields blurred edges and headaches, the exact failure a boxed gadget invites. When Meta and EssilorLuxottica shipped optical-first Ray-Ban styles built for prescriptions in March 2026, they pushed the product from novelty sunglasses toward daily eyewear that a licensed optician has to dispense and adjust. One optometrist’s account puts VSP and EyeMed coverage on the frames at parity with any prescription pair, leaving a plan holder near $350 out of pocket after allowances, with the electronics themselves unreimbursed. Best Buy cannot file that claim, and a phoropter is not shelf furniture. The prescription lens is the moat, because it forces the sale into a room only optical retail runs.

The growth is a channel story before it is a product story. EssilorLuxottica posted first-quarter 2026 revenue of €7.1 billion, up 10.8% at constant rates, its third straight quarter of double-digit gains. The company named AI glasses the driver across both wholesale and its own stores, and the eyewear group’s fastest-growing line is now the one it builds with a software company. That turns shelf space, fitting chairs and insurance rails into strategic infrastructure rather than back-office cost.

That growth is not free. EssilorLuxottica’s adjusted gross margin fell 2.6 points to 60.9% in 2025, and executives said the glasses business drove roughly two-thirds of that decline. The optical-retail moat is capturing volume and reimbursement right now, not yet margin, while Meta’s device carries a hardware cost the frame side is absorbing. If that mix holds, optical retail stops being where glasses are sold and becomes where a computing platform is placed on a face.


The same counter now hosts a fight over who keeps the margin. Meta’s economics reward volume and low prices, because the glasses are a path onto the face, then to the assistant, and eventually to the advertising Meta sells everywhere else. For EssilorLuxottica, the profit sits in margin per frame, not in units shipped. The two run through one channel, and trade reporting says they have already clashed over pricing, even as they jointly bet on a $299 entry model to widen the funnel. Whoever sets the price at the counter decides whether the optical store stays a premium boutique or turns into a volume gateway. That question, not the hardware, is what the partnership has left open.

The strongest objection is that none of this is about optometry at all. On that reading, Ray-Ban Meta sells through optical stores only because Meta’s partner owns them, which keeps brand, shelf and reimbursement inside one firm and makes the result a closed loop rather than a lesson about where face-worn computing belongs. For the thesis to fail, a rival made by a company that owns no optical chain would have to route around the optometrist and sell through consumer electronics instead. That rival exists, and it did the opposite. Google and Samsung’s Android XR glasses, previewed for a fall 2026 launch, are being built with Warby Parker and Gentle Monster — eyewear retailers that sell prescriptions through their own shops, not a consumer-electronics chain. Two large technology platforms, deciding independently, put their glasses where prescriptions are measured, which is the lens asserting itself as a channel rather than one firm’s vertical integration.

What follows is a repricing of the optometrist’s shelf. If glasses become the housing for a camera, a microphone and an assistant, then the counter that fits and insures them controls access to the fastest-selling new category the eyewear trade has, and that footfall is worth more to a platform than to a lensmaker. Meta has already taken a stake and is reported to be weighing a larger one, which is what a company does when it needs a channel it cannot build in time. The exposed party is everyone without those assets: a brand with no exam room, no dispensing optician and no payer contract now faces a distribution question it cannot answer with a website. The chains, the independents and the vision plans that hold them can rent that access at their price, or watch two platforms set the terms. The optical counter spent a century selling correction; it is about to learn what it is worth as a computer store.